Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease

H. Rheinallt Parri, Caterina M. Hernandez, Kelly T. Dineley

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Aberrant amyloid-β peptide (Aβ) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that Aβ is bound to α7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the α7 nAChR-Aβ interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.

Original languageEnglish (US)
Pages (from-to)931-942
Number of pages12
JournalBiochemical Pharmacology
Volume82
Issue number8
DOIs
StatePublished - Oct 15 2011

Fingerprint

alpha7 Nicotinic Acetylcholine Receptor
Alzheimer Disease
Nicotinic Receptors
Research
Amyloid
Brain
Therapeutics

Keywords

  • Alzheimer's disease
  • Amyloid
  • Cholinergic
  • Neuroprotection
  • Oligomer
  • Review

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology

Cite this

Research update : Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. / Parri, H. Rheinallt; Hernandez, Caterina M.; Dineley, Kelly T.

In: Biochemical Pharmacology, Vol. 82, No. 8, 15.10.2011, p. 931-942.

Research output: Contribution to journalArticle

Parri, H. Rheinallt ; Hernandez, Caterina M. ; Dineley, Kelly T. / Research update : Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. In: Biochemical Pharmacology. 2011 ; Vol. 82, No. 8. pp. 931-942.
@article{ddccb997eb8e44c2afe4cc1877c7b6fa,
title = "Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease",
abstract = "Aberrant amyloid-β peptide (Aβ) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that Aβ is bound to α7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the α7 nAChR-Aβ interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.",
keywords = "Alzheimer's disease, Amyloid, Cholinergic, Neuroprotection, Oligomer, Review",
author = "Parri, {H. Rheinallt} and Hernandez, {Caterina M.} and Dineley, {Kelly T.}",
year = "2011",
month = "10",
day = "15",
doi = "10.1016/j.bcp.2011.06.039",
language = "English (US)",
volume = "82",
pages = "931--942",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Research update

T2 - Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease

AU - Parri, H. Rheinallt

AU - Hernandez, Caterina M.

AU - Dineley, Kelly T.

PY - 2011/10/15

Y1 - 2011/10/15

N2 - Aberrant amyloid-β peptide (Aβ) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that Aβ is bound to α7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the α7 nAChR-Aβ interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.

AB - Aberrant amyloid-β peptide (Aβ) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that Aβ is bound to α7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the α7 nAChR-Aβ interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.

KW - Alzheimer's disease

KW - Amyloid

KW - Cholinergic

KW - Neuroprotection

KW - Oligomer

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=80052033738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052033738&partnerID=8YFLogxK

U2 - 10.1016/j.bcp.2011.06.039

DO - 10.1016/j.bcp.2011.06.039

M3 - Article

C2 - 21763291

AN - SCOPUS:80052033738

VL - 82

SP - 931

EP - 942

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 8

ER -